Table 1 Characteristics of the study population (n = 987)
Age (years) (range) | 61 (24–94) |
|---|---|
Male sex | 800 (81) |
Current smokers | 474 (48) |
Previous CVD | 229 (23) |
Treated hypertension | 334 (34) |
Treated diabetes mellitus | 124 (12) |
BMI (kg/m2) | 26.6 (24.3,29.2) |
Prehospital thrombolysis | 119 (12) |
Aspirin | 231 (23) |
Statins | 233 (23) |
Total cholesterol (mmol/L) | 4.9 (4.1,5.6) |
HDL (mmol/L) | 1.06 (0.88,1.30) |
Triglycerides (mmol/L) | 1.25 (0.89,1.78) |
CRP (mg/L) | 13.4 (7.0,31.3) |
Admission glucose (mmol/L) | 7.4 (6.3,9.0) |
Fasting glucose (mmol/L) | 5.8 (5.2,6.6) |
HbA1c (%) | 5.9 (5.6,6.3) |
Peak Troponin T (ng/L) | 3850 (1710,7250) |
NT-ProBNP (pmol/L) | 31 (10,118) |
LV Ejection fraction (%) | 50 (44,55) |
D-dimer (ng/mL) | 456 (287,796) |
F1 + 2 (pmol/L) | 246 (178,356) |
ETP (nM⋅min) | 1564 (1366,1743) |
Time from onset of symptoms to blood sampling (hours) (range) | 24 (5–118) |